Previous studies have demonstrated that BRG1 generally functions as a tumor suppressor via various mechanisms, including upregulation of the cell cycle inhibitor p21, a direct target gene of BRG1 (20,21). The gene discussed is SMARCA4; the disease is neoplasm.